The following Structured Product Label (SPL) was submitted to the FDA by Cardinal Health 107, Llc for the product Mag-al Plus Xs (NDC 55154-9422). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding other, otc - purpose, uses for the relief of:, otc - do not use, ask a doctor before use if you have, ask a doctor or pharmacist before use if you are, stop use and ask a doctor if, otc - keep out of reach of children, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Drug Facts
MANUFACTURED BY
Pharmaceutical
Associates, Inc.
Greenville, SC 29605
www.paipharma.com
Distributed By:
Cardinal Health
Dublin, OH 43017
L36154990525
F1762300721
| Active ingredients (in each 5 mL = 1 teaspoonful) | Purpose |
|---|---|
Aluminum hydroxide (equiv. to dried gel, USP) 400 mg | Antacid |
Magnesium hydroxide 400 mg | Antacid |
Simethicone 40 mg | Antigas |
Do not take more than 8 teaspoonfuls in a 24-hour period or use the maximum dosage for more than 2 weeks except under the advice and supervision of a physician.
Keep out of reach of children.
adults and children 12 years and older | take 2 to 4 teaspoonfuls two times a day or as directed by a physician |
children under 12 years | consult a physician |
Overbagged with 5 x 30 mL unit dose cups in each bag, NDC 55154-9422-5
WARNING: This Unit Dose package is not child resistant and is Intended for Institutional Use Only. Keep this and all drugs out of the reach of children.
*Maalox is a registered trademark of Novartis Consumer Health, Inc.
Butylparaben, hydroxypropyl methylcellulose, flavoring, propylene glycol, propylparaben, purified water, sodium saccharin, and sorbitol solution.
NDC 55154-9422-5
MAG-AL PLUS XS
5 CUPS
2400mg/2400mg/240mg In 30ml Bag Label (B950b648 4292 4b99 Ad30 52f554434f27 00)
* Please review the disclaimer below.
